Join us when CFO Kim Drapkin explains how she prioritizes the different aspects of her finance leadership role inside the biotech sector and reveals the different experiences that helped to prepare her to lead inside the entrepreneurial world of a mission-driven company.
Made Possible By
2018 Milestones
“We have our first clinical data coming out this year. So our priorities are making sure that we’ve educated our investor base over the next six months before that data comes out and positioned ourselves so that when our data arrives, people understand. Biotech is not like other industries where everything is clear. There are so many different immunotherapy drugs and so many different indications, so we’re going to be spending a lot of time making sure that our analysts and our investors understand the market, the space within, and where we’ll be competing.” –Kim Drapkin, CFO, Jounce Therapeutics